These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8965765)

  • 41. [Clinical course, diagnosis and treatment of ovarian tumors and cysts in children].
    Litovkoa VK; Zhurilo IP; Kononuchenko VP; Moskalenko VZ; Kharagezov AM
    Klin Khir; 1998; (6):28-9. PubMed ID: 9989046
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Secretome Identifies Tenascin-X as a Potent Marker of Ovarian Cancer.
    Kramer M; Pierredon S; Ribaux P; Tille JC; Petignat P; Cohen M
    Biomed Res Int; 2015; 2015():208017. PubMed ID: 26090390
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Medical and surgical treatment of functional ovarian cysts].
    Brun JL; Le Touzé O; Leng JJ
    J Gynecol Obstet Biol Reprod (Paris); 2001 Nov; 30(1 Suppl):S41-52. PubMed ID: 11917375
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Non-Hodgkin's lymphoma presenting as a pelvic mass with elevated CA-125.
    Allen GW; Forouzannia A; Bailey HH; Howard SP
    Gynecol Oncol; 2004 Sep; 94(3):811-3. PubMed ID: 15350377
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sarcoidosis associated with an elevated serum CA 125 level: description of a case and a review of the literature.
    Kalluri M; Judson MA
    Am J Med Sci; 2007 Dec; 334(6):441-3. PubMed ID: 18091365
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Meigs' syndrome with elevated serum CA 125 levels: two case reports and review of the literature.
    Timmerman D; Moerman P; Vergote I
    Gynecol Oncol; 1995 Dec; 59(3):405-8. PubMed ID: 8522265
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The association with age, human tissue kallikreins 6 and 10 and hemostatic markers for survival outcome from epithelial ovarian cancer.
    Koh SC; Razvi K; Chan YH; Narasimhan K; Ilancheran A; Low JJ; Choolani M;
    Arch Gynecol Obstet; 2011 Jul; 284(1):183-90. PubMed ID: 20680316
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Ovarian cysts. The respective role of clinical examination, echography, biological markers and cytology].
    Forest AM; Brémond A; Lévèque J; Viallet A
    J Gynecol Obstet Biol Reprod (Paris); 1990; 19(7):829-36. PubMed ID: 2277165
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Benign ovarian tumor with ascites and high serum levels of CA125: report of 3 cases].
    Li HJ; Shen K; Lang JH; Wu M; Huang HF; Pan LY
    Zhonghua Fu Chan Ke Za Zhi; 2003 Mar; 38(3):147-9. PubMed ID: 12816688
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic value of CA 125 in ovarian cyst fluid of patients with epithelial ovarian cancer.
    Kolwijck E; Span PN; Thomas CM; Bulten J; Sweep FC; Massuger LF
    Oncol Rep; 2010 Feb; 23(2):579-84. PubMed ID: 20043124
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
    Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
    Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Laparoscopic ovarian surgery. Panel discussion at the 21st annual meeting of the American Association of Gynecologic Laparoscopists (AAGL). September 25, 1992.
    Parker WH; Nezhat F; Canis M
    J Am Assoc Gynecol Laparosc; 1993 Nov; 1(1):78-84. PubMed ID: 9050467
    [No Abstract]   [Full Text] [Related]  

  • 53. Serum, pleural effusion, and ascites CA-125 levels in ovarian cancer and nonovarian benign and malignant diseases: a comparative study.
    Topalak O; Saygili U; Soyturk M; Karaca N; Batur Y; Uslu T; Erten O
    Gynecol Oncol; 2002 Apr; 85(1):108-13. PubMed ID: 11925128
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ovarian hyperstimulation-like syndrome after administration of triptorelin to a woman with endometriosis.
    Inaudi P; Mazzini M; D'Aniello G; Trusso P; Joghtapour A; Petraglia F
    Gynecol Endocrinol; 2002 Oct; 16(5):403-5. PubMed ID: 12587535
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management and outcome of borderline ovarian tumors incidentally discovered at or after laparoscopy.
    Darai E; Teboul J; Fauconnier A; Scoazec JY; Benifla JL; Madelenat P
    Acta Obstet Gynecol Scand; 1998 Apr; 77(4):451-7. PubMed ID: 9598957
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Management of ovarian cysts.
    Salat-Baroux J; Merviel P; Kuttenn F
    BMJ; 1996 Nov; 313(7065):1098. PubMed ID: 8916689
    [No Abstract]   [Full Text] [Related]  

  • 57. Benign Hydronephrosis and Elevated of Serum Levels of Carbohydrate Antigen CA 19-9: A Case Report.
    Filipovic B; Milinić N; Gacic J; Markovic O; Djokovic A; Filipovic B
    Am J Case Rep; 2016 Jun; 17():395-7. PubMed ID: 27287959
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Peritoneum and tissues of the female reproductive tract as physiological sources of CA-125.
    Zeimet AG; Offner FA; Müller-Holzner E; Widschwendter M; Abendstein B; Fuith LC; Daxenbichler G; Marth C
    Tumour Biol; 1998; 19(4):275-82. PubMed ID: 9679738
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hydronephrosis caused by a giant ovarian cyst.
    Kim HY; Cho MK; Bae EH; Kim SW; Ma SK
    Int Braz J Urol; 2016; 42(4):848-9. PubMed ID: 27564301
    [No Abstract]   [Full Text] [Related]  

  • 60. [Accessory role of the anomalous vessels in hydronephrosis developed in the affected kidney, and on the other side, limited form of cystic disease].
    WOLFROMM G; JANVIER R
    J Urol Medicale Chir; 1951; 57(11-12):833-40. PubMed ID: 14928312
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.